|
Volumn 332, Issue 8607, 1988, Pages 361-365
|
RISK-BENEFIT RATIO OF SODIUM FLUORIDE TREATMENT IN PRIMARY VERTEBRAL OSTEOPOROSIS
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CALCITONIN;
CALCIUM;
ERGOCALCIFEROL;
ETIDRONIC ACID;
FLUORIDE SODIUM;
CLINICAL TRIAL;
CONTROLLED STUDY;
HUMAN;
MAJOR CLINICAL STUDY;
ORAL DRUG ADMINISTRATION;
OSTEOPOROSIS;
PAIN;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RISK BENEFIT ANALYSIS;
VERTEBRA;
VERTEBRA FRACTURE;
ADMINISTRATION, ORAL;
AGED;
AGED, 80 AND OVER;
ANKLE;
CALCIUM;
CLINICAL TRIALS;
DRUG ADMINISTRATION SCHEDULE;
DRUG EVALUATION;
DRUG THERAPY, COMBINATION;
FEMALE;
FOLLOW-UP STUDIES;
FOOT;
FRACTURES, SPONTANEOUS;
GASTROINTESTINAL DISEASES;
HUMAN;
MALE;
MIDDLE AGE;
OSTEOPOROSIS;
PAIN;
RANDOM ALLOCATION;
RISK FACTORS;
SODIUM FLUORIDE;
SPINAL DISEASES;
SPINAL INJURIES;
SUPPORT, NON-U.S. GOV'T;
|
EID: 0023809288
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(88)92834-6 Document Type: Article |
Times cited : (214)
|
References (20)
|